In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: A novel role for CD44 in the process of peritoneal implantation

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1228-1232

  Strobel, Thomas ^a   Swanson, Linda ^a   Cannistra, Stephen A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ARTICLE; ASCITES FLUID ANALYSIS; CANCER CELL; CANCER GRAFT; CELL ADHESION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE OBSTRUCTION; MOUSE; NONHUMAN; OVARY CANCER; PERITONEAL CAVITY; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; CELL ADHESION; CELL DIVISION; DIAPHRAGM; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030895244     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cannistra, S. A. Cancer of the ovary. N. Engl. J. Med., 329: 1550-1559, 1993.
2. Cannistra, S. A., Kansas, G. S., Niloff, J., DeFranzo, B., Kirn, Y., and Ottensmeier, C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res., 53: 3830-3838, 1993.
3. Cannistra, S. A., DeFranzo, B., Niloff, J., and Ottensmeier, C. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines. Clin. Cancer Res., 1: 333-342, 1995.
4. Rheinwald, J. G. Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells. In: R. Baserga (ed.), Cell Growth and Division, A Practical Approach, pp. 81-94. Oxford: IRL Press Ltd., 1984.
5. Sy, M. S., Guo, Y. J., and Stamenkovic, I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med., 174: 859-866, 1991.
6. Sy, M. S., Guo, Y. J., and Stamenkovic, I. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. Exp. Med., 176: 623-627, 1992.
7. Birch, M., Mitchell, S., and Hart, I. R. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res., 51: 6660-6667, 1991.
8. Hofmann, M., Rudy, W., Zoller, M., Tolg, C., Ponta, H., Herrlich, P., and Gunthert, U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51: 5292-5297, 1991.
9. Koopman, G., Heider, K. H., Horst, E., Adolf, G. R., van den Berg, F., Ponta, H., Herrlich, P., and Pals, S. T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med., 177: 897-904, 1993.
10. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
11. Weilenga, V. J. M., Heider, K-H., Offerhaus, G. J. A., Adolf, G. R., van den Berg, F. M., Ponta, H., Herrlich, P., and Pals, S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53: 4754-4756, 1993.
12. Gross, N., Beretta, C., Peruisseau, G., Jackson, D., Simmons, D., and Beck, D. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res., 54: 4238-4242, 1994.
13. Cannistra, S. A., Graziella, A-J., Niloff, J., Strobel, T., Swanson, L., Andersen, J., and Ottensmeier, C. CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. J. Clin. Oncol., 13: 1912-1921, 1995.